Clinical Trial Update: Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) [Phase 2]

View source ↗

Summary

A Phase 2 adjuvant trial of bemiparin for small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Bemiparin (bemiparin)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Carcinoma, Small Cell | Phase 2 | Status: TERMINATED